Advertisement

The Scientist

» innovation, disease/medicine and neuroscience

Most Recent

image: Speaking of Science

Speaking of Science

By | February 1, 2016

February 2016's selection of notable quotes

1 Comment

image: The Mycobiome

The Mycobiome

By | February 1, 2016

The largely overlooked resident fungal community plays a critical role in human health and disease.

10 Comments

image: Infection-Autism Link Explained?

Infection-Autism Link Explained?

By | January 31, 2016

A mouse study suggests a mechanism by which severe infections during pregnancy increase autism risk. 

0 Comments

image: Schizophrenia and the Synapse

Schizophrenia and the Synapse

By | January 27, 2016

Genetic evidence suggests that overactive synaptic pruning drives development of schizophrenia.

5 Comments

image: More Evidence of Alzheimer’s Transmission

More Evidence of Alzheimer’s Transmission

By | January 27, 2016

Examining the brains of seven patients who died of the prion disease called Creutzfeldt–Jakob, researchers find signs of Alzheimer’s pathology. 

1 Comment

image: Processing Faces

Processing Faces

By | January 21, 2016

Other people’s faces are mapped onto our brains.

0 Comments

image: Cocaine Induces Neuronal Autophagy

Cocaine Induces Neuronal Autophagy

By | January 19, 2016

A new study supports the idea that cocaine triggers brain cells to eat themselves and suggests a possible antidote.

2 Comments

image: Who Owns CRISPR, Cont’d

Who Owns CRISPR, Cont’d

By | January 14, 2016

The US Patent and Trademark Office declares a patent “interference” and will seek to determine who has rights to the gene-editing technology.

1 Comment

image: How Blasts Affect the Brain

How Blasts Affect the Brain

By | January 13, 2016

Repeated exposure to explosions can damage the cerebellum in combat veterans and mouse models alike.

0 Comments

image: Brain-Training Firm, FTC Settle

Brain-Training Firm, FTC Settle

By | January 6, 2016

San Francisco-based Lumos Labs, creator of the brain-training program Lumosity, will pay $2 million to settle deceptive-advertising charges raised by the US Federal Trade Commission.

0 Comments

Advertisement
QIAGEN ingenuity
QIAGEN ingenuity

Popular Now

  1. The Zombie Literature
    Features The Zombie Literature

    Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?

  2. First Data from Anti-Aging Gene Therapy
  3. Locating Language within the Brain
  4. The Two Faces of Fish Oil
    Notebook The Two Faces of Fish Oil

    The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

Advertisement
SomaLogic
SomaLogic
Advertisement
RayBioTech